UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel strategies in immune checkpoint inhibitor drug development: How far are we from the paradigm shift?

British journal of clinical pharmacology, 2020-09, Vol.86 (9), p.1753-1768

2020

Volltextzugriff (PDF)

Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab

Journal for immunotherapy of cancer, 2022-06, Vol.10 (6), p.e004378

2022

Volltextzugriff (PDF)

Migrating Polyarthritis as a Feature of Occult Malignancy: 2 Case Reports and a Review of the Literature

Case reports in oncological medicine, 2015-01, Vol.2015 (2015), p.1-7

2015

Volltextzugriff (PDF)

Evaluating the Time to Palliative Care Referrals in Patients With Small-Cell Lung Cancer: A Single-Centre Retrospective Review

American journal of hospice & palliative medicine, 2018-11, Vol.35 (11), p.1426-1432

2018

Volltextzugriff (PDF)

Real-World Experience of Palbociclib-Induced Adverse Events and Compliance With Complete Blood Count Monitoring in Women With Hormone Receptor–Positive/HER2-Negative Metastatic Breast Cancer

Clinical breast cancer, 2019-02, Vol.19 (1), p.e186-e194

2019

Volltextzugriff (PDF)

Evaluation of hyperprogression in patients with sarcoma treated with targeted therapy and/or immunotherapy in early-phase clinical trials

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11560-11560

2023

Volltextzugriff (PDF)

Metronomic dosing of selinexor in select soft tissue sarcomas (STS)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11557-11557

2023

Volltextzugriff (PDF)

Sexual health and therapy adherence of hormone-sensitive breast cancer survivors on maintenance endocrine therapy: The SHE-CAN project in Toronto, Canada

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.536-536

2024

Volltextzugriff (PDF)

Phase 1b study of weekly split-dose selinexor in soft tissue sarcoma (STS)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.11563-11563

2022

Volltextzugriff (PDF)

A real-world experience of palbociclib-induced adverse events in women with HR-positive/Her2-negative metastatic breast cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13061-e13061

2018

Volltextzugriff (PDF)

Patient experience of early high grade symptomatic adverse events on early phase clinical trials using the PRO-CTCAE

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.12051-12051

2021

Volltextzugriff (PDF)

Mapping PRO-CTCAE responses to clinician-graded adverse events, dose reductions, interruptions, and discontinuations in phase I cancer trials

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.2014-2014

2020

Volltextzugriff (PDF)

An increase in serum choline levels to predict progression-free survival (PFS) in patients (pts) with advanced cancers receiving pembrolizumab

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3102-3102

2020

Volltextzugriff (PDF)

Prospective manipulation of the gut microbiome with Microbial Ecosystem Therapeutic 4 (MET4) in locoregionally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation (ROMA2)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.6059-6059

2021

Volltextzugriff (PDF)

BRCA1/BRCA2 predictive genetic testing in an Irish population: A missed opportunity

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13530-e13530

2018

Volltextzugriff (PDF)

The accuracy of pre-operative MRI in predicting the rectal cancer tumour stage, node status and complete clinical response in patients who have undergone neoadjuvant chemoradiotherapy using histopathologic analysis as the reference standard

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e15142-e15142

2016

Volltextzugriff (PDF)

Toxicities in immunotherapy: Can they predict response?

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14534-e14534

2016

Volltextzugriff (PDF)

Does immune checkpoint inhibitor-induced thyroid dysfunction impact on side effect profile? A restrospective cohort study

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14535-e14535

2016

Volltextzugriff (PDF)

Exome sequencing of metastatic medullary thyroid cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e23000-e23000

2016

Volltextzugriff (PDF)

Gastrointestinal Stromal Tumours: A 10 Year Multicenter Audit

Cancer and clinical oncology, 2016-10, Vol.6 (1), p.1

2016

Volltextzugriff (PDF)

Enteroscopic Management of Ectopic Varices in a Patient with Liver Cirrhosis and Portal Hypertension

Case Reports in Hepatology, 2016-01, Vol.2016 (2016), p.1-4

2016

Volltextzugriff (PDF)

A Patient with Testicular Seminoma, Inguinal Lymphadenopathy and Abnormal Pet Scan

International Journal of Cancer and Oncology, 2017, Vol.4 (1), p.1-4

2017

Volltextzugriff (PDF)

Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis

Journal of allergy and clinical immunology, 2014-07, Vol.134 (1), p.82-91

2014

Volltextzugriff (PDF)

Fire management for biodiversity conservation: Key research questions and our capacity to answer them

Biological conservation, 2010-09, Vol.143 (9), p.1928-1939

2010

Volltextzugriff (PDF)

A structured jet explains the extreme GRB 221009A

Science advances, 2023-06, Vol.9 (23), p.eadi1405-eadi1405

2023

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(58)
Reviews
(12)
Bücher
(1)

Sprache

Englisch
(71)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(19)
Humans
(18)
Female
(9)
Male
(9)
Biological And Medical Sciences
(7)
Adult
(6)
Medical Sciences
(6)
Middle Aged
(6)
Aged
(5)
Animals
(5)
Mice
(4)
Oncology
(4)
Aged, 80 And Over
(3)
Cancer
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Immunology
(3)
Immunotherapy
(3)
Polymorphism, Single Nucleotide
(3)
Time Factors
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Novel strategies in immune checkpoint inhibitor drug development: How far are we from the paradigm shift?

Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab

Migrating Polyarthritis as a Feature of Occult Malignancy: 2 Case Reports and a Review of the Literature

Evaluating the Time to Palliative Care Referrals in Patients With Small-Cell Lung Cancer: A Single-Centre Retrospective Review

Real-World Experience of Palbociclib-Induced Adverse Events and Compliance With Complete Blood Count Monitoring in Women With Hormone Receptor–Positive/HER2-Negative Metastatic Breast Cancer

Evaluation of hyperprogression in patients with sarcoma treated with targeted therapy and/or immunotherapy in early-phase clinical trials

Metronomic dosing of selinexor in select soft tissue sarcomas (STS)

Sexual health and therapy adherence of hormone-sensitive breast cancer survivors on maintenance endocrine therapy: The SHE-CAN project in Toronto, Canada

Phase 1b study of weekly split-dose selinexor in soft tissue sarcoma (STS)

A real-world experience of palbociclib-induced adverse events in women with HR-positive/Her2-negative metastatic breast cancer

Patient experience of early high grade symptomatic adverse events on early phase clinical trials using the PRO-CTCAE

Mapping PRO-CTCAE responses to clinician-graded adverse events, dose reductions, interruptions, and discontinuations in phase I cancer trials

An increase in serum choline levels to predict progression-free survival (PFS) in patients (pts) with advanced cancers receiving pembrolizumab

Prospective manipulation of the gut microbiome with Microbial Ecosystem Therapeutic 4 (MET4) in locoregionally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation (ROMA2)

BRCA1/BRCA2 predictive genetic testing in an Irish population: A missed opportunity

The accuracy of pre-operative MRI in predicting the rectal cancer tumour stage, node status and complete clinical response in patients who have undergone neoadjuvant chemoradiotherapy using histopathologic analysis as the reference standard

Toxicities in immunotherapy: Can they predict response?

Does immune checkpoint inhibitor-induced thyroid dysfunction impact on side effect profile? A restrospective cohort study

Exome sequencing of metastatic medullary thyroid cancer

Gastrointestinal Stromal Tumours: A 10 Year Multicenter Audit

Enteroscopic Management of Ectopic Varices in a Patient with Liver Cirrhosis and Portal Hypertension

A Patient with Testicular Seminoma, Inguinal Lymphadenopathy and Abnormal Pet Scan

Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis

Fire management for biodiversity conservation: Key research questions and our capacity to answer them

A structured jet explains the extreme GRB 221009A

Suchergebnisse filtern